Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
about
Coronavirus HKU1 and other coronavirus infections in Hong KongCharacterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumoniaBTS Guidelines for the Management of Community Acquired Pneumonia in AdultsAlcohol reversibly disrupts TNF-alpha/TACE interactions in the cell membraneAlcohol Use As a Risk Factor in Infections and Healing: A Clinician's PerspectiveMacrophage phagocytosis: effects of environmental pollutants, alcohol, cigarette smoke, and other external factorsTranscriptome Profiling Reveals Disruption of Innate Immunity in Chronic Heavy Ethanol Consuming Female Rhesus MacaquesGuidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and preventionEpidemiology and management of common pulmonary diseases in older personsStaphylococcus aureus community-onset pneumonia in patients admitted to children's hospitals during autumn and winter of 2006-2007.Predictors of viral pneumonia: the need for viral testing in all patients hospitalized for nursing home-acquired pneumonia.Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markersThe blind nasotracheal aspiration method is not a useful tool for pathogen detection of pneumonia in childrenCausative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban populationMycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).An evaluation of prescribing practices for community-acquired pneumonia (CAP) in Mongolia.Community-acquired Pseudomonas aeruginosa-pneumonia in a previously healthy man occupationally exposed to metalworking fluidsPatients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort.Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital.Severe community-acquired Enterobacter pneumonia: a plea for greater awareness of the concept of health-care-associated pneumonia.Epigallocatechin gallate, a potential immunomodulatory agent of tea components, diminishes cigarette smoke condensate-induced suppression of anti-Legionella pneumophila activity and cytokine responses of alveolar macrophages.Respiratory syncytial virus infection in adultsEthanol upregulates glucocorticoid-induced leucine zipper expression and modulates cellular inflammatory responses in lung epithelial cellsChildhood Hib vaccination and pneumonia and influenza burden in US seniorsCommunity-acquired pneumonia in elderly patients.Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumoniaSeroepidemiology of human bocavirus infection in Jamaica.Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults.Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controlsAlcohol, host defence and society.Significance of anaerobes and oral bacteria in community-acquired pneumonia.Body mass index and risk of pneumonia: a systematic review and meta-analysis.Ethanol-induced alcohol dehydrogenase E (AdhE) potentiates pneumolysin in Streptococcus pneumoniae.Pneumococcal vaccination and revaccination of older adults.Microbial infections, immunomodulation, and drugs of abuse.A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.Development of a new resequencing pathogen microarray based assay for detection of broad-spectrum respiratory tract viruses in patients with community-acquired pneumonia.The challenge of nonresolving pneumonia. Knowing the norms of radiographic resolution is key.Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults.Trends in pathogens among patients hospitalized for pneumonia from 1993 to 2011.
P2860
Q24549102-8757E7B2-F536-4EBC-B81C-5F67876DF29DQ24558699-F8BD1CE6-4FE9-4D9A-8661-80644FE2C987Q24675547-183ABFA7-E236-41F1-99D2-4D2A5DDB9D88Q24812187-C87C5194-52DE-400F-8B2F-026C4F1ED1C2Q26773242-1B67D06F-0BD7-47B3-9417-DFAF09C2B8DFQ27006556-64D8B075-3EAB-4E69-AB14-640D66777A88Q27334505-31CB9B7B-FE32-4ACA-BA61-3F03E65265EDQ28201389-4B9A5585-6109-4110-ACC3-C648807526CBQ28397465-4977EF80-ED05-4DAA-A301-E75F8EC1AB50Q30227401-59DD01E6-E4D0-42EC-86C4-1761B7E6F34AQ30427611-1DD6EBE5-AFEB-4E15-83AB-56763371FF2BQ30821176-AB448198-B147-4FCC-96B4-8DFBDBC5934DQ30995024-1CDA5321-419B-408B-80B9-5847531E8D61Q33418963-51B46AB6-D389-4D25-B4CC-ED14A894BE0BQ33445332-2D87BA45-548A-48E9-9155-53B620F45547Q33592516-DFEF9E82-FE17-4296-BA7C-3602A03E1D23Q33727224-BB1C7713-5EBC-44CB-BDB4-ABEC1212A451Q33752549-0E99F22F-5A9E-40D5-B10A-AF88D63E8E45Q33843896-3544ADCF-9AF6-4F3B-BDF5-B23BB7A5BCA3Q33898654-0552616F-1C1D-485F-B10F-4596FE6F6207Q33943663-3F6ECB3B-A569-42C5-97EF-C00B59BBB60EQ33961877-0BE93488-BF58-42FE-ABFD-10AEC120747AQ33982654-F8111E6C-59F6-4682-8F32-F572B7CDFED6Q34044178-AF07220C-3924-4720-AF21-5261F91E2DE1Q34048462-BB04AE2F-AB9C-4AEA-9062-030A79261C89Q34151093-BF2BAB1C-1B75-49DE-9CBA-A835037DACC4Q34292922-A8ABC808-4662-476F-A519-8D54E766E48EQ34462623-9298E335-F457-41AB-ABDC-138C3DC796F7Q34539087-0F5911D9-DD04-4D99-AB12-293B24D1ED21Q34576431-8D945AA1-7340-4DA4-B1E2-CD6976AC9DEDQ34720997-88708403-10E2-49BC-8C89-90DAE1634478Q34783541-0D55E8F8-497B-4FCE-99AC-7783ECD45685Q34889616-C3D63229-E5F4-4F0C-9C40-82C388904ADDQ34926870-6F667EE1-1FD8-44C2-A350-BC2CD327CDC8Q34926928-9214F61A-133C-4335-B7C3-6DB6C564B341Q34991328-F04C12DD-438A-48F0-A6DD-F682630FA447Q35005913-36340494-E142-4BE6-83A5-04E099C31676Q35052574-21D6CF4B-7361-49F5-B905-B49B20826C55Q35075184-7289DDE3-0A4B-41CB-8240-7D3FB0F7159FQ35087078-1AD69A34-BA4E-46CA-AE0C-D58094FA97F1
P2860
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
@en
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
@nl
type
label
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
@en
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
@nl
prefLabel
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
@en
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
@nl
P2093
P2860
P1476
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.
@en
P2093
Arancibia F
Martinez JA
P2860
P304
P356
10.1164/AJRCCM.160.2.9808045
P407
P577
1999-08-01T00:00:00Z